Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EPHX2 | P34913 | 6/20 | 0.51 |
| ▸ | CYP2D6 | P10635 | 3/20 | 0.51 |
| ▸ | SLC6A4 | P31645 | 9/20 | 0.48 |
| ▸ | SLC6A3 | Q01959 | 9/20 | 0.48 |
| ▸ | SLC6A2 | P23975 | 7/20 | 0.48 |
| ▸ | TACR3 | P29371 | 5/20 | 0.46 |
| ▸ | TACR2 | P21452 | 4/20 | 0.46 |
| ▸ | TACR1 | P25103 | 4/20 | 0.46 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.45 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.45 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.45 |
| ▸ | CYP2C8 | P10632 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8593197 | 0.86 | SLC6A4 (0.51) | EPHX2CYP2D6SLC6A4SLC6A3SLC6A2 | |
| SCHEMBL8296260 | 0.85 | TACR3 (0.44) | EPHX2CYP2D6SLC6A4SLC6A3TACR3 | |
| SCHEMBL3466847 | 0.83 | CCR5 (0.51) | EPHX2CYP2D6SLC6A4SLC6A3SLC6A2 | |
| SCHEMBL13345602 | 0.83 | CCR5 (0.51) | EPHX2CYP2D6SLC6A4SLC6A3SLC6A2 | |
| SCHEMBL8300813 | 0.82 | TACR1 (0.58) | CYP2D6TACR3TACR2TACR1CYP3A4 | |
| SCHEMBL8742504 | 0.80 | CCR5 (0.51) | CYP2D6TACR3TACR2TACR1CYP3A4 | |
| SCHEMBL6950742 | 0.78 | TACR2 (0.66) | EPHX2CYP2D6SLC6A4SLC6A3SLC6A2 | |
| SCHEMBL6544379 | 0.77 | CCR5 (0.49) | EPHX2CYP2D6SLC6A4SLC6A3SLC6A2 | |
| SCHEMBL7955246 | 0.77 | CCR5 (0.49) | EPHX2CYP2D6SLC6A4SLC6A3SLC6A2 | |
| SCHEMBL5200438 | 0.77 | SLC6A2 (0.51) | CYP2D6SLC6A4SLC6A3SLC6A2TACR3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0512901-B1 | Aminated polycyclic compounds and their enantiomers, process for their preparation and pharmaceutical compositions containing them | SANOFI SA (FR) | 1999-06-23 | — | — | EP | disclosed |
| US-5625060-A | Polycyclic amine compounds and their enantiomers, their method of preparation and pharmaceutical compositions on which they are present | Sanofi, Elf (FR) | 1997-04-29 | — | — | US | disclosed |
| US-5340822-A | Substance P, neurokinin antagonists | ELF SANOFI (FR) | 1994-08-23 | — | — | US | disclosed |
| EP-0512901-A1 | Aminated polycyclic compounds and their enantiomers, process for their preparation and pharmaceutical compositions containing them | SANOFI (FR) | 1992-11-11 | — | — | EP | disclosed |